Methods/design
prostate cancer
PROSTATE CANCER
MANCAN2 is a phase III multicentre, randomised controlled trial and process evaluation of guided self-help cognitive behavioural therapy to manage the impact of HFNS symptoms in patients with prostate cancer undergoing androgen deprivation therapy.